Gastric Volvulus Treatment Global Market Report 2025

Description

Gastric volvulus treatment involves surgical interventions, specifically focusing on volvulus reduction and the reintegration of the stomach into the abdominal cavity, especially in cases of intrathoracic migration. The treatment also addresses the correction of causal factors. Gastric volvulus surgery is typically a straightforward procedure, encompassing de-rotation, lowering of hernial contents into the abdominal wall, and repair of the hernial defect.

The main types of gastric volvulus treatment are organo-axial and mesentero-axial volvulus. Organo-axial volvulus occurs when the abdomen undergoes a 180-degree spin around its long axis, resulting in this condition. Treatment options include medication and surgery, with various routes of administration such as oral and parenteral. Distribution channels for these treatments include hospital pharmacies and retail pharmacies, serving purposes in hospitals, home healthcare, specialty clinics, and other healthcare settings.

The gastric volvulus treatment market research report is one of a series of new reports from. The Business Research Company that provides gastric volvulus treatment market statistics, including gastric volvulus treatment industry global market size, regional shares, competitors with a gastric volvulus treatment market share, detailed gastric volvulus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gastric volvulus treatment industry. This gastric volvulus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $27.36 billion in 2024 to $28.95 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research and clinical studies.

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $37.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, adoption of advanced imaging techniques. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, and customized treatment approaches.

A growing geriatric population is projected to drive the expansion of the gastric volvulus treatment market in the future. The geriatric population refers to older adults aged 65 and above, who are prone to various diseases due to decreased immunity and aging. Gastric volvulus is primarily seen in individuals over the age of 50. Consequently, the increase in the geriatric population is expected to boost the market. For example, in January 2024, statistics from the Population Reference Bureau (PRB), a US-based nonprofit organization, indicated that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is projected to grow from 17% to 23%. Therefore, the rising geriatric population is a key driver of the gastric volvulus treatment market.

The rising prevalence of gastrointestinal diseases is anticipated to drive the growth of the gastric volvulus treatment market in the upcoming years. Gastrointestinal diseases refer to medical conditions that affect the internal structures of the gastrointestinal (GI) tract, often referred to as gastrointestinal disorders, including ailments such as gastritis, inflammatory bowel disease, and gastric cancer. The comprehensive care provided during gastric volvulus treatment may encompass strategies and considerations that enhance the overall health of the gastrointestinal system and its related disorders. For example, in September 2022, Cancer Australia, an organization focused on cancer awareness and support for individuals affected by cancer in Australia and its territories, reported that there were an estimated 2,572 new cases of stomach cancer expected to be diagnosed in Australia in 2022 (1,661 males and 911 females). In 2022, the likelihood of developing stomach cancer by age 85 was 1 in 114 (or 0.87%), with the odds being 1 in 1.1 (87%) for men and 1 in 167 (0.60%) for women. Thus, the increasing incidence of gastrointestinal diseases is propelling the gastric volvulus treatment market.

Product innovations emerge as a prominent trend gaining traction in the gastric volvulus treatment market. Major companies in the market are introducing innovative products to maintain their competitive positions. For instance, in October 2023, Pfizer Inc., a pharmaceutical company based in the United States, announced the FDA approval of VELSIPITY (etrasimod) for people with moderate to severe active ulcerative colitis. This once-daily oral sphingosine-1-phosphate (S1P) receptor activator offers a positive benefit-risk profile, providing adults with an effective, steroid-free resolution through a convenient oral pill.

Companies operating in the gastric volvulus treatment market are focusing on product innovations such as digital radiology solutions to enhance radiologists' efficiency. A digital radiology solution involves leveraging digital technology in medical imaging for visualizing internal body structures and aiding in the diagnosis and management of conditions such as gastric volvulus through digital image capture and analysis. For instance, in February 2023, Carestream Health India Pvt. Ltd. launched the DRX Compass, a digital radiological solution designed for accuracy, convenience, and customization. This innovative solution empowers radiologists with heightened productivity and flexibility in configuring the system based on individual requirements.

Key players in the gastric volvulus treatment market are concentrating on developing innovative solutions like advanced hyperbaric oxygen therapy to improve access to cutting-edge medical treatments, thereby enhancing patient outcomes and community health. Advanced hyperbaric oxygen therapy (HBOT) is a medical procedure that involves inhaling 100% oxygen in a pressurized chamber, which enhances oxygen delivery to tissues and promotes healing. This therapy may prove beneficial in the treatment of gastric volvulus by improving tissue oxygenation and aiding recovery from ischemia or surgical procedures. For example, in December 2024, HBOT India, a medical facility in India that specializes in hyperbaric oxygen therapy, introduced Medical Grade 3 ATA Hyperbaric Oxygen Therapy. This treatment enhances healing by increasing oxygen absorption, making it effective for chronic wounds, decompression sickness, and various other conditions. Its launch in Gurgaon significantly broadens access to advanced medical treatments in the area, thereby supporting the health and well-being of the community.

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastric volvulus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric volvulus treatment market includes revenues earned by entities that perform laparotomy, gastric detorsion, and gastric fixation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Volvulus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric volvulus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric volvulus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastric volvulus treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus
2) By Treatment Type: Medication; Surgery
3) By Route Of Administration: Oral; Parenteral
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches
Companies Mentioned: PAI Pharma; Sun Pharmaceutical Industries Ltd.; ANI Pharmaceuticals Inc.; Fresenius SE and Co. KGaA; Mayne Pharma Group Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23395

1. Executive Summary

2. Gastric Volvulus Treatment Market Characteristics

3. Gastric Volvulus Treatment Market Trends And Strategies

4. Gastric Volvulus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Gastric Volvulus Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Gastric Volvulus Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastric Volvulus Treatment Market Growth Rate Analysis
5.4. Global Gastric Volvulus Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastric Volvulus Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastric Volvulus Treatment Total Addressable Market (TAM)

6. Gastric Volvulus Treatment Market Segmentation

6.1. Global Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Organo-Axial Volvulus
Mesentero-Axial Volvulus
6.2. Global Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Surgery
6.3. Global Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.4. Global Gastric Volvulus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
6.5. Global Gastric Volvulus Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.6. Global Gastric Volvulus Treatment Market, Sub-Segmentation Of Organo-Axial Volvulus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Intervention
Endoscopic Management
Gastropexy
Other Treatment Methods
6.7. Global Gastric Volvulus Treatment Market, Sub-Segmentation Of Mesentero-Axial Volvulus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Intervention
Gastropexy
Endoscopic Techniques
Other Treatment Approaches

7. Gastric Volvulus Treatment Market Regional And Country Analysis

7.1. Global Gastric Volvulus Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastric Volvulus Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastric Volvulus Treatment Market

8.1. Asia-Pacific Gastric Volvulus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastric Volvulus Treatment Market

9.1. China Gastric Volvulus Treatment Market Overview
9.2. China Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastric Volvulus Treatment Market

10.1. India Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastric Volvulus Treatment Market

11.1. Japan Gastric Volvulus Treatment Market Overview
11.2. Japan Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastric Volvulus Treatment Market

12.1. Australia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastric Volvulus Treatment Market

13.1. Indonesia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastric Volvulus Treatment Market

14.1. South Korea Gastric Volvulus Treatment Market Overview
14.2. South Korea Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastric Volvulus Treatment Market

15.1. Western Europe Gastric Volvulus Treatment Market Overview
15.2. Western Europe Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastric Volvulus Treatment Market

16.1. UK Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastric Volvulus Treatment Market

17.1. Germany Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastric Volvulus Treatment Market

18.1. France Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastric Volvulus Treatment Market

19.1. Italy Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastric Volvulus Treatment Market

20.1. Spain Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastric Volvulus Treatment Market

21.1. Eastern Europe Gastric Volvulus Treatment Market Overview
21.2. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastric Volvulus Treatment Market

22.1. Russia Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastric Volvulus Treatment Market

23.1. North America Gastric Volvulus Treatment Market Overview
23.2. North America Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastric Volvulus Treatment Market

24.1. USA Gastric Volvulus Treatment Market Overview
24.2. USA Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastric Volvulus Treatment Market

25.1. Canada Gastric Volvulus Treatment Market Overview
25.2. Canada Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastric Volvulus Treatment Market

26.1. South America Gastric Volvulus Treatment Market Overview
26.2. South America Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastric Volvulus Treatment Market

27.1. Brazil Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastric Volvulus Treatment Market

28.1. Middle East Gastric Volvulus Treatment Market Overview
28.2. Middle East Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastric Volvulus Treatment Market

29.1. Africa Gastric Volvulus Treatment Market Overview
29.2. Africa Gastric Volvulus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastric Volvulus Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastric Volvulus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastric Volvulus Treatment Market Competitive Landscape And Company Profiles

30.1. Gastric Volvulus Treatment Market Competitive Landscape
30.2. Gastric Volvulus Treatment Market Company Profiles
- 30.2.1. PAI Pharma Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. ANI Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Mayne Pharma Group Limited Overview, Products and Services, Strategy and Financial Analysis

31. Gastric Volvulus Treatment Market Other Major And Innovative Companies

31.1. Sawai Pharmaceutical Co.Ltd.
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Glenmark Pharmaceuticals Ltd.
31.4. Tris Pharma Inc.
31.5. Pfizer Inc.
31.6. Mallinckrodt Pharmaceuticals
31.7. GlaxoSmithKline plc
31.8. Endo International plc
31.9. Vintage Labs
31.10. Zydus Group
31.11. Bayer AG
31.12. AbbVie Inc.
31.13. Amgen Inc.
31.14. Johnson & Johnson Services Inc.
31.15. UCB S.A.

32. Global Gastric Volvulus Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

34. Recent Developments In The Gastric Volvulus Treatment Market

35. Gastric Volvulus Treatment Market High Potential Countries, Segments and Strategies

35.1 Gastric Volvulus Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Gastric Volvulus Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Gastric Volvulus Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer